Effectiveness of Antiseizure Medication Triple Therapy in Patients With Glioma With Refractory Epilepsy-Reference-Cited by-同舟云学术

Effectiveness of Antiseizure Medication Triple Therapy in Patients With Glioma With Refractory Epilepsy

Published:2023-04-04 Issue:14 Volume:100 Page:
ISSN:0028-3878
Container-title:Neurology
language:en
Short-container-title:Neurology

Author:

van der Meer Pim B.¹^ORCID,Dirven Linda¹,Fiocco Marta¹,Vos Maaike J.¹,Kouwenhoven Mathilde C.M.¹^ORCID,van den Bent Martin J.¹,Taphoorn Martin J.B.¹,Koekkoek Johan A.F.¹

Affiliation:

1. From the Leiden University Medical Center (P.B.v.d.M., L.D., M.F., M.J.V., M.J.B.T., J.A.F.K.); Haaglanden Medical Center (P.B.v.d.M., L.D., M.J.V., J.A.F.K.), The Hague; Amsterdam University Medical Centers (M.C.M.K.); and Erasmus Medical Center (M.J.v.d.B.), Rotterdam, the Netherlands.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Neurology (clinical)

Link

https://www.neurology.org/doi/pdfdirect/10.1212/WNL.0000000000206852

Reference31 articles.

1. Association Between IDH1 and IDH2 Mutations and Preoperative Seizures in Patients with Low-Grade Versus High-Grade Glioma: A Systematic Review and Meta-Analysis

2. Epilepsy in glioma patients: mechanisms, management, and impact of anticonvulsant therapy: Table 1.

3. Predictors of early, recurrent, and intractable seizures in low-grade glioma

4. Effect of valproic acid on seizure control and on survival in patients with glioblastoma multiforme

5. Clobazam: A Safe, Efficacious, and Newly Rediscovered Therapeutic for Epilepsy

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clobazam/Levetiracetam/Valproic-acid;Reactions Weekly;2024-06-22

2. IDH1 mutation predicts seizure occurrence and prognosis in lower-grade glioma adults;Pathology - Research and Practice;2024-02

3. New possibilities of overcoming pharmacoresistance in epilepsy;Medical alphabet;2024-01-19

4. Brain tumor-related epilepsy management: A Society for Neuro-oncology (SNO) consensus review on current management;Neuro-Oncology;2023-09-12